Find your next M&A target

Target Asia + Worldwide M&A projects with our guidance on matching, planning, due diligence & implementation.

Project details

Korean AI medical diagnosis firm seeks USD 2.5 million investment

Project region Korea
Industry Healthcare
Total value of the target N/A
Expected target net rate of return after deducting all taxes and fees N/A
Validity period of pending order 365

CONTACT ADVISOR

  • Simon Laube

    Simon Laube

    Senior Associate, International Business Advisory

Project highlights AI diagnosis - national system
Project description

The Korean AI medical company's products include a cervical cancer diagnosis AI system, an early AI diagnosis for stroke risk, a stroke risk prediction AI system based ob carotid ultrasound images, and a cerebral aneurysm rupture risk prediction AI system based on cerebral angiography images. The company has developed a international system with various languages to ensure that all medical personnel around the world can use its AI diagnosis solutions. Its partners include Swedish medical device manufacturer Gynius plus AB and Canadian health care company Variational AI. The company seeks USD 2.5 million for equity financing.

Enquire for more information about our services, and how we can help solve challenges for your organization

Contact Us
The code is case-sensitive